Search Results for "Who Is Cutting Edge With Thyroid Cancer"
Original Source: Cutting Edge: The Etiology of Autoimmune Thyroid Diseases.
Significant progress has been made in our understanding of the mechanisms leading to autoimmune thyroid diseases (AITD). For the first time, we are beginning to unravel these mechanisms at the molecular level. AITD, including Graves' disease (GD) and Hashimoto's thyroiditis (HT), are common autoimmune diseases affecting the thyroid. They have a complex etiology that involves genetic and environmental influences. Seven genes have been shown to contribute to the etiology of AITD. The first AITD gene discovere...
Matching Channels
Matching News
[Comment] Treating advanced radioresistant differentiated thyroid cancer
Despite a decline in overall mortality from cancer in the USA, thyroid cancer incidence has more than doubled in the past decade, with an associated rise in mortality. Equivalent or even more pronounc...
Thyroid Journal Publishes First Comprehensive Guidelines For Managing Anaplastic Thyroid Cancer
Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and fol...
First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
(Mary Ann Liebert, Inc./Genetic Engineering News) Naplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagn...
Thyroid cancer is the ninth most common cancer in the United States, with an incidence that has been increasing sharply since the mid-1990s. The majority of thyroid cancers are papillary thyroid cance...
Thyroid journal publishes new ATA guidelines for management of anaplastic thyroid cancer
Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and fol...
FDA approves Exelixis drug for treatment of rare thyroid cancer
The FDA has approved Exelixis’ Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasised). Medullary thyroid cancer develops in cells in the...
FDA approves drug for rare thyroid cancer
The Food and Drug Administration on Thursday approved a new drug to treat a rare form of thyroid cancer after it has spread to other parts of the body.The agency cleared Cometriq from Exelixis Inc. f...
Cometriq (Cabozantinib) For Medullary Thyroid Cancer Approved By FDA
Cometriq (cabozantinib) has been approved by the FDA for the treatment of progressive medullary thyroid cancer that has metastasized - spread to other parts of the body. Medullary thyroid cancer, a ra...
Matching PubMed Articles
Controlled chattering-a new 'cutting-edge' technology for nanofabrication.
Chatters are unwanted random defects on surfaces often generated in cutting samples via microtome for micrographic analysis. In this work, we demonstrate that chatters can actually be controlled for f...
Design and characterization of nanoknife with buffering beam for in situ single-cell cutting.
A novel nanoknife with a buffering beam is proposed for single-cell cutting. The nanoknife was fabricated from a commercial atomic force microscopy (AFM) cantilever by focused-ion-beam (FIB) etching t...
A one-step approach for the fabrication of polymer and metal nanowires.
The fabrication of one-dimensional (1D) polymer and metal nanowires were obtained in a one-step mechanical approach. This approach is based on a controlled chattering process at the cutting edge of an...
Cutting-Edge Issues in Organ-Specific Autoimmunity.
There have been numerous methods and ways to classify autoimmune diseases. By far, the most traditional has been to separate immune-mediated pathology into organ-specific and organ-non-specific diseas...
